הכנסות ממכירות החברה galmedpharma.com (GLMD)

Galmed Pharmaceuticals Ltd - לוגו גרפי של המנפיק GLMD

Galmed Pharmaceuticals (GLMD) has established a biotech ecosystem for liver therapy centered around the Aramchol molecule, securing an exclusive scientific sector. The company's sales performance demonstrates revenue dynamics, where 0.00 represents the current metric level. Currently, high clinical trial costs are hindering development. In the future, the company plans to monetize its patents through partnerships with global industry leaders.

GLMD הכנסות ונפח מכירות Galmed Pharma (04.07.2022 - 10.09.2026)

פילוחים אנליטיים של חברת Galmed Pharmaceuticals

- מחיר שוק ויעדי מחיר של אנליסטים:
ניתוח מסכם של החברה:GLMD (Galmed Pharmaceuticals Ltd.)
פריט של המותג Galmed Pharmaceuticals

Daily revenue measures actual cash flow from customers, smoothing out speculative noise to identify systemic degradation or the true scale of business operations. By analyzing the company's sales revenue, investors assess the stability of cash inflows, which for Galmed Pharmaceuticals (GLMD) confirms the effectiveness of implementing ESG standards and strict biosafety in the development of liver disease treatments.